Keysight Technologies has released the new Machine Learning Toolkit in the latest Keysight Device Modelling Software Suite.
Dynamic prediction of cancer-associated thrombosis to guide prophylactic anticoagulation. Age distribution of metastatic cancer patients and chemotherapy discontinuation rates.
In an interview with Technology Networks, Dr. Daniel Reker discusses how machine learning is improving data-scarce areas of ...
The ability to anticipate what comes next has long been a competitive advantage -- one that's increasingly within reach for developers and organizations alike, thanks to modern cloud-based machine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results